References
- Agache, I. and Rogozea, L., 2017. Asthma biomarkers: Do they bring precision medicine closer to the clinic? Allergy, asthma and immunology research, 9, 466–476.
- Allman, D., et al., 2001. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. Journal of immunology (Baltimore, Md. : 1950), 167, 6834–6840.
- Bandyopadhyay, A., et al., 2013. Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients. Lung India: official organ of Indian chest society, 30, 117–123.
- Bohlson, S.S., et al., 2005. CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma. Journal of immunology (Baltimore, Md.: 1950), 175, 1239–1247.
- Bousquet, J., et al., 1990. Eosinophilic inflammation in asthma. The new England journal of medicine, 323, 1033–1039.
- Byeon, J.H., et al., 2017. Association between sensitization to mold and impaired pulmonary function in children with asthma. Allergy asthma & immunology research, 9, 509–516.
- Greenlee, M.C., Sullivan, S.A., and Bohlson, S.S., 2008. CD93 and related family members: their role in innate immunity. Current drug targets, 9, 130–138.
- Greenlee-Wacker, M.C., Galvan, M.D., and Bohlson, S.S., 2012. CD93: recent advances and implications in disease. Current drug targets, 13, 411–420.
- Guan, E., et al., 1994. Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. Journal of immunology (Baltimore, Md. : 1950), 152, 4005–4016.
- Hastie, A.T., et al., 2013. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. Journal of allergy and clinical immunology, 132, 72–80.
- Izuhara, K., Ohta, S., and Ono, J., 2016. Using periostin as a biomarker in the treatment of asthma. Allergy, asthma and immunology research, 8, 491–498.
- Jeon, J.W., et al., 2010. Soluble CD93 induces differentiation of monocytes and enhances TLR responses. Journal of immunology (Baltimore, Md. : 1950), 185, 4921–4927.
- Kim, D.K., et al., 2016a. Korean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014. Tuberculosis and respiratory diseases), 79, 111–120.
- Kim, S.H., et al., 2016b. Association of specific immunoglobulin E to staphylococcal enterotoxin with airway hyperresponsiveness in asthma patients. Tuberculosis and respiratory disorders (Seoul), 79, 295–301.
- Kim, S.R., et al., 2017. Current epidemiological data on asthma management in South Korea from qualitative assessment of asthma management by health insurance review and assessment service (HIRA). Tuberculosis and respiratory diseases, 80, 221–225.
- Ko, A.R., et al., 2016. High-sensitivity C-reactive protein can reflect small airway obstruction in childhood asthma. Yonsei medical journal, 57, 690–697.
- Lee, J.H., et al., 2013. A novel human anti-VCAM-1 monoclonal antibody ameliorates airway inflammation and remodelling. Journal of cellular and molecular medicine, 17, 1271–1281.
- McKearn, J.P., Baum, C., and Davie, J.M., 1984. Cell surface antigens expressed by subsets of pre-B cells and B cells. Journal of immunology, 132, 332–339.
- Moore, W.C., et al., 2014. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. Journal of Allergy and clinical immunology, 133, 1557–1563. e1555.
- Moosig, F., et al., 2006. C1qRP (CD93) expression on peripheral blood monocytes in patients with systemic lupus erythematosus. Rheumatology international, 26, 1109–1112.
- Ober, C., et al., 2008. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. The new England journal of medicine, 358, 1682–1691.
- Park, H.J., et al., 2017. Soluble CD93 in serum as a marker of allergic inflammation. Yonsei medical journal, 58, 598–603.
- Pilling, D., et al., 2009. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One, 4, e7475.
- Sigari, N., et al., 2016. Soluble CD93 as a novel biomarker in asthma exacerbation. Allergy, asthma and immunology research, 8, 461–465.
- Turk, B.E., et al., 2001. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nature biotechnology, 19, 661–667.
- Woodruff, P.G., et al., 2009. T-helper type 2-driven inflammation defines major subphenotypes of asthma. American journal of respiratory and critical care medicine, 180, 388–395.